fda announcement semaglutide FDA-Approved Oral Pills for Weight Loss A big win for Wegovy:

Some researchers experiment with splitting the dose into two half-doses (3.75 mg each) administered 3 to 4 days apart to reduce GI side effects

GLP-1 therapy typically requires extended treatment duration, with most patients needing 12-24 months to achieve significant outcomes and establish weight maintenance patterns

This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Yin, J., Ye, J

*Note, patent A is a continuation of Patent B which is further a continuation of Patent C

Magnesium lactate and magnesium chloride : These forms are also generally well-absorbed and may be suitable options